Intranasal Insulin in Parkinson's Disease

NCT04251585 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: Regular Novolin R
DRUG: Placebo

Sponsor

HealthPartners Institute